Proteomics International Laboratories
Proteomics International Laboratories Ltd (ASX:PIQ) is a medical technology company specializing in predictive diagnostics and bio-analytical services. They focus on proteomics, the industrial-scale study of protein structure and function, to develop novel diagnostic tests like PromarkerD, PromarkerEndo, and PromarkerEso, aiming to bring these to global markets.
Short position
Proteomics International Laboratories (ASX:PIQ) has 0.40% of its shares on issue reported as short positions as of 5 Oct 2026, or about 653,303 shares. Over the past 30 days that figure has fallen 0.25 percentage points, and over 90 days it has been broadly flat. Its highest recorded short interest was 0.71% in August 2026. PIQ is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4Proteomics International Laboratories (PIQ) company profile
Profile, insiders and operations
Company
AI-generated research profile of Proteomics International Laboratories
PIQ intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links